125 related articles for article (PubMed ID: 1681867)
21. Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancer.
Wilke H; Preusser P; Stahl M; Harstrick A; Meyer HJ; Achterrath W; Schmoll HJ; Seeber S
Cancer Chemother Pharmacol; 1991; 29(1):83-4. PubMed ID: 1742854
[TBL] [Abstract][Full Text] [Related]
22. Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies.
Barone C; Corsi DC; Pozzo C; Cassano A; Fontana T; Noviello MR; Landriscina M; Colloca G; Astone A
Cancer; 1998 Apr; 82(8):1460-7. PubMed ID: 9554521
[TBL] [Abstract][Full Text] [Related]
23. Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study.
Adamo V; Scimone A; Maisano R; Altavilla G; Ferraro G; Laudani A; Pergolizzi S; Zanghì M
J Chemother; 1999 Feb; 11(1):74-7. PubMed ID: 10078785
[TBL] [Abstract][Full Text] [Related]
24. Treatment of advanced gastric cancer with the combination fluorouracil, leucovorin, etoposide, and cisplatin: a phase II study of the ONCOPAZ Cooperative Group.
González-Barón M; Feliu J; Espinosa E; García-Girón C; Chacón I; Garrido P; Colmenarejo A; Ordóñez A; Zamora P
Cancer Chemother Pharmacol; 1995; 36(3):255-8. PubMed ID: 7781148
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy of gastric cancer.
Schipper DL; Wagener DJ
Anticancer Drugs; 1996 Feb; 7(2):137-49. PubMed ID: 8740718
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
[TBL] [Abstract][Full Text] [Related]
27. Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research.
Cocconi G; Bella M; Zironi S; Algeri R; Di Costanzo F; De Lisi V; Luppi G; Mazzocchi B; Rodinò C; Soldani M
J Clin Oncol; 1994 Dec; 12(12):2687-93. PubMed ID: 7989945
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study.
Ott K; Sendler A; Becker K; Dittler HJ; Helmberger H; Busch R; Kollmannsberger C; Siewert JR; Fink U
Gastric Cancer; 2003; 6(3):159-67. PubMed ID: 14520529
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy in gastric cancer: an economic evaluation of the FAM (5-fluorouracil, adriamycin, mitomycin C) versus ELF (etoposide, leucovorin, 5-fluorouracil) regimens.
Norum J; Angelsen V
J Chemother; 1995 Oct; 7(5):455-9. PubMed ID: 8596132
[TBL] [Abstract][Full Text] [Related]
30. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
[TBL] [Abstract][Full Text] [Related]
31. [Chemotherapy of scirrhous gastric cancer].
Wakui A
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2398-406. PubMed ID: 7944483
[TBL] [Abstract][Full Text] [Related]
32. [Etoposide, doxorubicin, cisplatin and 5-FU (EAP-F) therapy of advanced gastric cancer--its antitumor effect and evaluation of quality of life].
Suda K; Kano Y; Inada T; Ogata Y
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1791-5. PubMed ID: 8379671
[TBL] [Abstract][Full Text] [Related]
33. Etoposide in gastric cancer.
Macdonald JS; Havlin KA
Semin Oncol; 1992 Dec; 19(6 Suppl 13):59-62. PubMed ID: 1492227
[TBL] [Abstract][Full Text] [Related]
34. Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer.
Içli F; Karaoguz H; Akbulut H; Dinçol D; Demirkazik A; Cay F
J Surg Oncol; 1997 Apr; 64(4):318-23. PubMed ID: 9142190
[TBL] [Abstract][Full Text] [Related]
35. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant chemotherapy with cisplatin, etoposide, fluorouracil and leucovorin for gastric carcinoma.
Papadakou M; Xydakis E; Bonios M; Makropoulou E; Boukis C; Kakavoulis T; Karaliotas C; Panagos G
J BUON; 2006; 11(3):285-9. PubMed ID: 17309151
[TBL] [Abstract][Full Text] [Related]
37. [Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
Jiang Y; Qiu XH; Yang YX; Zhang SQ; Chen ZM
Ai Zheng; 2006 Aug; 25(8):1029-34. PubMed ID: 16965688
[TBL] [Abstract][Full Text] [Related]
38. Current strategies in the management of locoregional and metastatic gastric carcinoma.
Ajani JA; Ota DM; Jackson DE
Cancer; 1991 Jan; 67(1 Suppl):260-5. PubMed ID: 1984825
[TBL] [Abstract][Full Text] [Related]
39. High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study.
Hofheinz RD; Hartung G; Samel S; Hochhaus A; Pichlmeier U; Post S; Hehlmann R; Queisser W
Onkologie; 2002 Jun; 25(3):255-60. PubMed ID: 12119460
[TBL] [Abstract][Full Text] [Related]
40. FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.
Bajetta E; Di Bartolomeo M; Carnaghi C; Buzzoni R; Mariani L; Gebbia V; Comella G; Pinotti G; Ianniello G; Schieppati G; Bochicchio AM; Maiorino L
Br J Cancer; 1998 Apr; 77(7):1149-54. PubMed ID: 9569054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
